-
China denounces US Senate’s $250bn move to boost tech and manufacturing | US news
China has denounced a US Senate bill worth about $250bn (£175n) that aims to boost American technology and manufacturing prowess as an example of the US hyping up “the so-called China threat”, and accused Washington of attempting to hinder its development. The Senate on Tuesday overwhelmingly approved the Innovation and Competition Act, in a rare show of unity in a chamber often filled with political division between Democrats and Republicans. The expansive legislation, passed by 68-32 votes, combines various China-related measures into what analysts have called the biggest piece of US industrial policy legislation in decades. In a scathing statement
-
Establishment of a COVID-19 mRNA vaccine technology transfer hub to scale up global manufacturing
WHO and its partners are seeking to expand the capacity of low- and middle-income countries (LMICs) to produce COVID-19 vaccines and scale up manufacturing to increase global access to these critical tools to bring the pandemic under control. WHO will facilitate the establishment of one (or more, as appropriate) technology transfer1 hub(s) that will use a hub and spoke model (REF) to transfer a comprehensive technology package and provide appropriate training to interested manufacturers in LMICs. This initiative will initially prioritize the mRNA-vaccine technology2 but could expand to other technologies in the future. The intention is for these
